Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Jon C. Ogg | Sep 4, 2014 at 4:45 PM EDT

What This Skin Cancer Drug Approval Really Means to Merck

Merck & Co. has received approval from the FDA to bring its new drug Keytruda to market.

Jon C. Ogg | Sep 3, 2014 at 5:58 PM EDT

Alarming Health Care Spending Forecasts as Percentage of GDP

ThinkstockThe Centers for Medicare and Medicaid Services (CMS) has projected that the current number of uninsured people is expected to…

Jon C. Ogg | Sep 3, 2014 at 2:10 PM EDT

Is Infinity Fully Valued Now, or Is More Upside Left?

Infinity Pharmaceuticals will partner with Abbvie to further develop and commercialize IPI-145, also known as Duvelisib.

Chris Lange | Sep 3, 2014 at 11:50 AM EDT

Credit Suisse Positive on Some Biotechs, Very Cautious on Others

Credit Suisse has launched new biotech coverage on Wednesday with two analysts at the firm.

Lee Jackson | Sep 3, 2014 at 10:45 AM EDT

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

A new report from the pharmaceutical team at Credit Suisse highlights four top stocks to buy for the remainder of…

Lee Jackson | Sep 3, 2014 at 8:55 AM EDT

ETF Rebalance Could Make 5 Biotech Stocks Shoot Higher

A Cowen report zeroes in on the most illiquid stocks that will be traded Wednesday as 15 ETFs rebalance.

Paul Ausick | Aug 30, 2014 at 9:30 AM EDT

E-Cigarettes Under Attack by World Health Organization

If the tobacco industry thought it had solved all its legal problems with the introduction of electronic cigarettes, the industry…

Chris Lange | Aug 27, 2014 at 2:00 PM EDT

Jaguar Animal Health Files for IPO

Jaguar Animal Health has filed with the U.S. Securities and Exchange Commission for an initial public offering.

Chris Lange | Aug 27, 2014 at 12:05 PM EDT

Calithera Files for IPO to Fund Cancer Tumor Therapy Projects

Calithera Biosciences files with the U.S. Securities and Exchange Commission to conduct an initial public offering.

Chris Lange | Aug 27, 2014 at 10:25 AM EDT

Rising Short Interest in Biotech Stocks

Short sellers might be inclined to bet against biotech companies because of their volatile behavior on the charts.

Chris Lange | Aug 26, 2014 at 10:50 AM EDT

Kite Pharma Surges on Positive Lymphoma Study of Only 13 Patients

Kite Pharma made a big hit in the after-hours market on Monday with its announcement of positive results in a…

Chris Lange | Aug 21, 2014 at 2:44 PM EDT

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

ThinkstockBristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) had…

Lee Jackson | Aug 20, 2014 at 8:40 AM EDT

6 Biotech Stocks to Buy Now With Up to 100% Upside Potential

ThinkstockWith the biotech space having its usual volatile ups and downs this year, the analysts at Stifel have stepped back…

Jon C. Ogg | Aug 13, 2014 at 9:53 AM EDT

What the Market Is Telling MannKind (Updated)

MannKind Corp. (NASDAQ: MNKD) was supposed to be a huge winner on this week’s news that Sanofi (NYSE: SNY) will…

Jon C. Ogg | Aug 12, 2014 at 12:54 PM EDT

Is an Impending Implosion of Dendreon Avoidable?

ThinkstockDendreon Corp. (NASDAQ: DNDN) has turned into one of those unsettling biotech stories: It went from great promise, to high…

1 … 282 283 284 285 286 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

What This Skin Cancer Drug Approval Really Means to Merck

Alarming Health Care Spending Forecasts as Percentage of GDP

Is Infinity Fully Valued Now, or Is More Upside Left?

Credit Suisse Positive on Some Biotechs, Very Cautious on Others

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

ETF Rebalance Could Make 5 Biotech Stocks Shoot Higher

E-Cigarettes Under Attack by World Health Organization

Jaguar Animal Health Files for IPO

Calithera Files for IPO to Fund Cancer Tumor Therapy Projects

Rising Short Interest in Biotech Stocks

Kite Pharma Surges on Positive Lymphoma Study of Only 13 Patients

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

6 Biotech Stocks to Buy Now With Up to 100% Upside Potential

What the Market Is Telling MannKind (Updated)

Is an Impending Implosion of Dendreon Avoidable?

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.

‘Your Knowledge of Money and How It Works Is Nil’: Suze Orman to 62-Year-Old Who Nearly Locked His Wife Into $605 a Month

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.

Health and Healthcare Articles

All Health and Healthcare Articles

What This Skin Cancer Drug Approval Really Means to Merck

Alarming Health Care Spending Forecasts as Percentage of GDP

Is Infinity Fully Valued Now, or Is More Upside Left?

Credit Suisse Positive on Some Biotechs, Very Cautious on Others

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

ETF Rebalance Could Make 5 Biotech Stocks Shoot Higher

E-Cigarettes Under Attack by World Health Organization

Jaguar Animal Health Files for IPO

Calithera Files for IPO to Fund Cancer Tumor Therapy Projects

Rising Short Interest in Biotech Stocks

Kite Pharma Surges on Positive Lymphoma Study of Only 13 Patients

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

6 Biotech Stocks to Buy Now With Up to 100% Upside Potential

What the Market Is Telling MannKind (Updated)

Is an Impending Implosion of Dendreon Avoidable?

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.

‘Your Knowledge of Money and How It Works Is Nil’: Suze Orman to 62-Year-Old Who Nearly Locked His Wife Into $605 a Month

Featured Reads

How a 61-Year-Old Built a $3,500 Monthly Paycheck From Just Two Funds: SCHD and JEPQ

He Worked 20 Years for the Railroad, Then 20 Years Off It. His Social Security Benefit Cut His Railroad Tier I Dollar for Dollar.